Common diabetes medications also reduce the risk of dementia, research shows
Australian experts have discovered that the common drug used in type 2 diabetes, metformin, not only controls blood glucose but also strengthens the brain, increasing the risk of dementia and other mental illnesses. Decreases. The study, conducted in collaboration with several medical institutes in New South Wales, Australia, was supported by data from a long-term study on aging and memory, launched in 2005. The study continues today, with 1,037 participants aged between 70 and 90. Of these, 127 were diabetics, who were exposed to metformin use and the likelihood of developing dementia.
The study was published online in the latest issue of the American Diabetes Association’s journal Diabetes Care. It should be noted that in 2017, the results of a study on metformin and cancer have been published, which showed that this drug additionally reduces the chances of various cancers. This is the first study of its kind on the relationship between metformin and dementia